Android app on Google Play

RBC Capital Starts Infinity Pharmaceutical (INFI) at Outperform

November 21, 2012 6:42 AM EST Send to a Friend
Get Alerts INFI Hot Sheet
Price: $11.14 -1.42%

Rating Summary:
    10 Buy, 5 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 13 | New: 52
Trade INFI Now!
Join SI Premium – FREE
RBC Capital initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Outperform. PT $28.00.

For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.

Shares of Infinity Pharmaceutical closed at $23.45 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

RBC Capital

Add Your Comment